• Mashup Score: 1

    Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis, on the first day of Fall Dermatology Week 2023.

    Tweet Tweets with this article
    • Unlocking new pathways to fight psoriasis! Dr. Jeffrey Cohen shares insights on TYK2 inhibitors as a promising therapeutic target. https://t.co/xUy7WDecXp #PsoriasisTreatment #DermatologyWeek #TYK2Inhibitors #Derm #Dermatology #Dermatologist #DermInsights #SkincareExperts

  • Mashup Score: 0

    In this feature video, Dr Kristina Callis-Duffin, MD, MS shares what will be presented during her session, “Psoriasis & Psoriatic Arthritis – So Now What Do I Do?”, at the 2023 Fall Clinical Dermatology Conference.

    Tweet Tweets with this article
    • In this feature video, Dr Kristina Callis-Duffin shares what will be presented during her session, “Psoriasis & Psoriatic Arthritis - So Now What Do I Do?”, at the 2023 Fall Clinical Dermatology Conference. https://t.co/vqup5dOpjj #FallClinical #Derm #Dermatology #Dermatologist

  • Mashup Score: 0

    A recent study published in Lasers in Surgery and Medicine has unveiled a promising treatment option for individuals dealing with acne and its often-persistent aftermath of scars. Researchers have discovered that combining the 1927nm fractional thulium fiber laser (TFL) with 30% supramolecular salicylic acid (SSA) chemical peels significantly improves both acne and acne scars.

    Tweet Tweets with this article
    • A recent study has unveiled a promising treatment option for individuals dealing with acne and its often-persistent aftermath of scars. Read More: https://t.co/yUpzt2EHtK #Derm #Dermatology #Dermatologist #DermInsights #SkincareExperts #Dermatology101 #DermatologyExperts

  • Mashup Score: 3

    The Spironolactone for Adult Female Acne, or SAFA, trial, which employed a pragmatic, multicenter, phase 3, double-blind, randomized controlled design to assess the impact of spironolactone on acne, revealed the effectiveness of oral spironolactone as a treatment for acne vulgaris in adult women.

    Tweet Tweets with this article
    • The Spironolactone for Adult Female Acne, or SAFA, trial revealed the effectiveness of oral spironolactone as a treatment for acne vulgaris in adult women. Read More: https://t.co/s1xqn3uk2n #Derm #Dermatology #Dermatologist #DermInsights #SkincareExperts #DermatologyExperts

  • Mashup Score: 0

    A preliminary study published in the Journal of Biophotonics has shed light on the potential of photodynamic diagnosis in evaluating acne inflammatory skin lesions. The study, which focused on the use of 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD), has showcased the potential of ALA-PDD as a valuable tool for evaluating acne inflammatory skin lesions.

    Tweet Tweets with this article
    • A preliminary study published in the Journal of Biophotonics has shed light on the potential of photodynamic diagnosis in evaluating #acne inflammatory skin lesions. Read More: https://t.co/K1cYc3Cdsv #Derm #Dermatology #Dermatologist #DermInsights

  • Mashup Score: 0

    In her Dermatology Week Fall 2023 session, “Health Disparities in Dermatology: Psoriasis,” Dr Junko Takeshita underscored the critical issue of health care disparities in dermatology.

    Tweet Tweets with this article
    • Addressing health disparities in #psoriasis care is crucial. Dr. Junko Takeshita sheds light on racial and ethnic disparities in #dermatology at Dermatology Week 2023. https://t.co/8IPLIavJMC #HealthDisparities #PsoriasisCare #Derm #Dermatologist #DermInsights #SkincareExperts